Matthew Ryan Sharpe, M.D.
NPI 1285775049ActiveIndividual· Internal Medicine, Pulmonary Disease· Kansas City, KS
Internal Medicine, Pulmonary Disease (M.D.) in Kansas City, Kansas, trained at University of Kansas School of Med (Kc/Wich/Sal) (class of 2000). Their prescriptions cost Medicare Part D more than their services did: $751,676 for 1,215 claims, against $46,767 paid for services in 2024. Genzyme Corporation was the largest of 4 companies reporting payments in 2025, $177,631 in all, mostly speaking and faculty fees.
Overview
| NPI | 1285775049 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Feb 12, 2007 |
| Last updated in NPPES | Sep 11, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 04-29868 | KS |
| Internal Medicine, Critical Care Medicine | 207RC0200X | 04-29868 | KS |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (KS) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 528 |
|---|---|
| Services billed | 1,159 across 34 procedure codes |
| Paid by Medicare | $46,767 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,215 · 1,783 30-day fills |
|---|---|
| Patients | 171 |
| Total drug cost | $751,676 |
| Generic share | 42% of claims |
Education and affiliations
| Medical school | University of Kansas School of Med (Kc/Wich/Sal) |
|---|---|
| Graduation year | 2000 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Critical Care (Intensivists), Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- Kansas University Physicians IncLenexa, KS · 1,849 clinicians
Hospital affiliations
- Stormont Vail HospitalTopeka, KS
- University of Kansas HospitalKansas City, KS
Industry payments (Open Payments)
- 2025$177,631 · 118 payments from 4 companies
- 2024$188,888 · 126 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Genzyme Corporation | $108,656 | 48 |
| Regeneron Healthcare Solutions, Inc. | $40,166 | 35 |
| Astrazeneca Pharmaceuticals LP | $25,375 | 29 |
| Glaxosmithkline, LLC. | $3,435 | 6 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$138,369 · 35 payments
- Consulting Fee$19,033 · 7 payments
- Travel and Lodging$17,484 · 40 payments
- Food and Beverage$2,746 · 36 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Pulmonary Disease providers in Kansas City
- 1275554099
- 1023685377
- 1801980438
- 1619192291
- 1881610004
- 1992201529
- 1871298315
- 1427074889
- 1659666709
- 1588758502
- 1780995720
- 1639632508
All Internal Medicine, Pulmonary Disease providers in Kansas →